Searched for
STERILE INJECTABLES
From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plansBiodeal Pharmaceuticals is set to broaden its horizons with a state-of-the-art sterile injectables plant in Himachal Pradesh. This venture ...- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhy should one be careful of the market at this juncture? One reason is that stocks are still not cheap. Even after all the nervousness of ...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsIn the short term, be ready for volatility, and do not mistake the passing of one big event for an all-clear. In the long term, give up try...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Hospital pricing part of wider value chain: Max MDAbhay Soi, chairman of Max Healthcare, commented on scrutiny regarding hospital pricing in India. He stated that hospitals should be evalua...
- Centre may seek legal view on licensing of sterile drugsThe government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...
- Drugs Panel to weigh bringing all sterile drug products under central licensing amid contamination concernsA proposal will soon be considered to centralize licensing for all sterile drug products. This move aims to tighten regulations on medicine...
- RBI uses currency swaps to cut $115 billion cash surplusIndia's central bank is draining excess cash from banks using currency swaps. This action follows record high funds in the financial system...
- Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 croreFosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...
- Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Ind...
- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- Jackson Labs' Baddi drug manufacturing licence restored after suspensionThe unit's licence was cancelled in June after several women in Kota, Rajasthan, died allegedly due to spurious oxytocin injections supplie...
- Zydus to make Biotax 1g injection available with 10ml sterile water post Nepal regulator's objectionThe Indian pharmaceuticals group refuted a media report that the Department of Drug Administration, Nepal has suspended sales and distribut...
- Swedish firm Recipharm buys majority stake in Nitin Lifesciences for Rs 671 croreSwedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...
- Strides Arcolab's Polish sterile facility gets USFDA nodStrides Arcolab today said its injectables unit Agila Specialties has received US Food and Drug Administration (USFDA) approval for its Pol...
- PE funds eye stake in Strides' injectables bizPrivate equity funds Carlyle Group and 3i, are among those holding preliminary discussions to take a substantial minority stake in pharmace...
- Strides Acrolab receives US FDA approvalThe Rs 1000 crore generic pharma company has received US FDA inspection approval status for its steriles injectable complex at Bangalore.
Load More
